Joanna Gajuk
Stock Analyst at B of A Securities
(3.16)
# 1,152
Out of 4,915 analysts
31
Total ratings
59.09%
Success rate
11.28%
Average return
Main Sectors:
Stocks Rated by Joanna Gajuk
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CHE Chemed | Maintains: Buy | $708 → $650 | $416.57 | +56.04% | 1 | Jun 30, 2025 | |
| CON Concentra Group Holdings Parent | Maintains: Buy | $24 → $25 | $20.40 | +22.55% | 4 | Jan 23, 2025 | |
| USPH U.S. Physical Therapy | Upgrades: Buy | $100 → $115 | $74.97 | +53.39% | 3 | Dec 16, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $19 → $21 | $21.31 | -1.45% | 2 | Dec 11, 2024 | |
| BKD Brookdale Senior Living | Downgrades: Underperform | $7.75 → $6 | $7.72 | -22.28% | 2 | Oct 7, 2024 | |
| SEM Select Medical Holdings | Reinstates: Buy | $42 | $14.48 | +190.06% | 1 | Aug 20, 2024 | |
| EHAB Enhabit | Maintains: Underperform | $9 → $8 | $6.68 | +19.76% | 2 | Jun 27, 2024 | |
| ADUS Addus HomeCare | Maintains: Buy | $115 → $118 | $108.37 | +8.89% | 2 | May 7, 2024 | |
| AHCO AdaptHealth | Maintains: Neutral | $13 → $11 | $9.13 | +20.48% | 2 | Sep 22, 2023 | |
| AMED Amedisys | Downgrades: Underperform | $145 → $102 | $98.74 | +3.30% | 8 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $5.5 | $3.99 | +38.02% | 1 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $48 | $75.63 | -36.53% | 3 | Feb 21, 2018 |
Chemed
Jun 30, 2025
Maintains: Buy
Price Target: $708 → $650
Current: $416.57
Upside: +56.04%
Concentra Group Holdings Parent
Jan 23, 2025
Maintains: Buy
Price Target: $24 → $25
Current: $20.40
Upside: +22.55%
U.S. Physical Therapy
Dec 16, 2024
Upgrades: Buy
Price Target: $100 → $115
Current: $74.97
Upside: +53.39%
BrightSpring Health Services
Dec 11, 2024
Maintains: Buy
Price Target: $19 → $21
Current: $21.31
Upside: -1.45%
Brookdale Senior Living
Oct 7, 2024
Downgrades: Underperform
Price Target: $7.75 → $6
Current: $7.72
Upside: -22.28%
Select Medical Holdings
Aug 20, 2024
Reinstates: Buy
Price Target: $42
Current: $14.48
Upside: +190.06%
Enhabit
Jun 27, 2024
Maintains: Underperform
Price Target: $9 → $8
Current: $6.68
Upside: +19.76%
Addus HomeCare
May 7, 2024
Maintains: Buy
Price Target: $115 → $118
Current: $108.37
Upside: +8.89%
AdaptHealth
Sep 22, 2023
Maintains: Neutral
Price Target: $13 → $11
Current: $9.13
Upside: +20.48%
Amedisys
Jun 21, 2022
Downgrades: Underperform
Price Target: $145 → $102
Current: $98.74
Upside: +3.30%
Mar 29, 2022
Downgrades: Neutral
Price Target: $10 → $5.5
Current: $3.99
Upside: +38.02%
Feb 21, 2018
Maintains: Buy
Price Target: $46 → $48
Current: $75.63
Upside: -36.53%